ARV-471

Drug identity checked against registry records

Also recorded as PF-07850327; Vepdegestrant

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryNCT05549505ARVNPhase 2Completed2024-07-13Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.